| 注册
首页|期刊导航|中国医药科学|前列地尔联合贝那普利治疗糖尿病肾病蛋白尿的临床疗效分析

前列地尔联合贝那普利治疗糖尿病肾病蛋白尿的临床疗效分析

陈菁华

中国医药科学Issue(16):57-59,3.
中国医药科学Issue(16):57-59,3.

前列地尔联合贝那普利治疗糖尿病肾病蛋白尿的临床疗效分析

Analysis of clinical effect of alprostadil combined benazepril treatment of diabetic renal proteinuria

陈菁华1

作者信息

  • 1. 济宁医学院附属医院药剂科,山东济宁 272113
  • 折叠

摘要

Abstract

Objective To study the clinical effect of alprostadil combined benazepril in the treatment of diabetic renal proteinuria.Methods 65 patients with diabetic renal proteinuria, who were treated in our hospital from July 2013 to February 2015, were selected and randomly divided into observation group(33 cases) and control group(32 cases). To compare the clinical effect, the content of 24h urinary protein, 24h urinary microalbumin excretive rate, and the situation of adverse reaction between control group which was treated with benazepril and observation group which was treated with alprostadil combined benazepril.Results The differences of total effective rate between observation group(93.94%) and control group(81.25%) was statically significant(P<0.05). The content of 24h urinary protein, 24h urinary microalbumin excretive rate of the two groups after treatment 8 weeks were obviously lower than which before treatment(P<0.05), and after treatment, which in observation group was obviously lower than which in control group(P<0.05). The differences of the total adverse reaction rate between observation group(6.06%) and control group(9.39%) were no statically significant compared with(P>0.05).Conclusion Alprostadil combined benazepril in the treatment of diabetic renal proteinuria has better clinical effect and lower adverse reaction.

关键词

前列地尔/贝那普利/糖尿病肾病/蛋白尿

Key words

Alprostadil/Benazepril/Diabetic nephropathy/Proteinuria

分类

医药卫生

引用本文复制引用

陈菁华..前列地尔联合贝那普利治疗糖尿病肾病蛋白尿的临床疗效分析[J].中国医药科学,2015,(16):57-59,3.

中国医药科学

2095-0616

访问量0
|
下载量0
段落导航相关论文